PharmaBlock Sciences (Nanjing) Balance Sheet Health
Financial Health criteria checks 4/6
PharmaBlock Sciences (Nanjing) has a total shareholder equity of CN¥2.9B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 51.5%. Its total assets and total liabilities are CN¥4.9B and CN¥2.0B respectively. PharmaBlock Sciences (Nanjing)'s EBIT is CN¥211.9M making its interest coverage ratio 5.1. It has cash and short-term investments of CN¥596.5M.
Key information
51.5%
Debt to equity ratio
CN¥1.49b
Debt
| Interest coverage ratio | 5.1x |
| Cash | CN¥596.54m |
| Equity | CN¥2.90b |
| Total liabilities | CN¥2.02b |
| Total assets | CN¥4.92b |
Recent financial health updates
PharmaBlock Sciences (Nanjing) (SZSE:300725) Takes On Some Risk With Its Use Of Debt
Nov 22
We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt
Jul 31Recent updates
PharmaBlock Sciences (Nanjing) (SZSE:300725) Takes On Some Risk With Its Use Of Debt
Nov 22PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce
Sep 30PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Aug 23We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt
Jul 31PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31
Jun 12PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Apr 21PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump
Mar 07Financial Position Analysis
Short Term Liabilities: 300725's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥806.3M).
Long Term Liabilities: 300725's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥1.2B).
Debt to Equity History and Analysis
Debt Level: 300725's net debt to equity ratio (30.9%) is considered satisfactory.
Reducing Debt: 300725's debt to equity ratio has increased from 12.3% to 51.5% over the past 5 years.
Debt Coverage: 300725's debt is not well covered by operating cash flow (19.2%).
Interest Coverage: 300725's interest payments on its debt are well covered by EBIT (5.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 09:37 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PharmaBlock Sciences (Nanjing), Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kai Wang | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |